{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:27:40Z","timestamp":1793939260613,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","award":["Grant\/2021\/PHF\/23776"],"award-info":[{"award-number":["Grant\/2021\/PHF\/23776"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","award":["FKZ 1369-227"],"award-info":[{"award-number":["FKZ 1369-227"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijmm.2026.151745","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:52:46Z","timestamp":1790869966000},"page":"151745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Increased circulation of influenza A(H1N1)pdm09 viruses with reduced susceptibility to oseltamivir, Germany 2024\u20132026"],"prefix":"10.1016","volume":"323","author":[{"given":"Susanne C.","family":"Duwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Naneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Milde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3432-0438","authenticated-orcid":false,"given":"Ralf","family":"D\u00fcrrwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmm.2026.151745_bib1","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1128\/JVI.02681-13","article-title":"Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets","volume":"88","author":"Abed","year":"2014","journal-title":"J. Virol."},{"issue":"67","key":"10.1016\/j.ijmm.2026.151745_bib2","doi-asserted-by":"crossref","DOI":"10.21105\/joss.03773","article-title":"Nextclade: clade assignment, mutation calling and quality control for viral genomes","volume":"6","author":"Aksamentov","year":"2021","journal-title":"J. Open. Source Softw."},{"key":"10.1016\/j.ijmm.2026.151745_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/aje\/kwp237","article-title":"Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States","volume":"170","author":"Basta","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ijmm.2026.151745_bib4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1099\/vir.0.017459-0","article-title":"Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic","volume":"91","author":"Boltz","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijmm.2026.151745_bib5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijmm.2026.151745_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004065","article-title":"'Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses'","volume":"10","author":"Butler","year":"2014","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.ijmm.2026.151745_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jmv.23986","article-title":"'Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs'","volume":"87","author":"Correia","year":"2015","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijmm.2026.151745_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2008.08.008","article-title":"'Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses'","volume":"81","author":"Deyde","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijmm.2026.151745_bib9","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/AAC.01417-09","article-title":"'Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing'","volume":"54","author":"Deyde","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2026.151745_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70530","article-title":"Atypical influenza A(H3N2) activity patterns in Germany, 2021-2023, and characterization of newly emerged virus clades","volume":"97","author":"Duwe","year":"2025","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijmm.2026.151745_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jviromet.2008.07.017","article-title":"A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1","volume":"153","author":"Duwe","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ijmm.2026.151745_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/v16071109","article-title":"Increase of synergistic secondary antiviral mutations in the evolution of A(H1N1)pdm09 influenza virus neuraminidases","volume":"16","author":"Duwe","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ijmm.2026.151745_bib13","article-title":"'Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations'","volume":"9","author":"Duwe","year":"2021","journal-title":"GMS Infect. Dis."},{"key":"10.1016\/j.ijmm.2026.151745_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.antiviral.2010.11.001","article-title":"Genotypic and phenotypic resistance of pandemic A\/H1N1 influenza viruses circulating in Germany","volume":"89","author":"Duwe","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijmm.2026.151745_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2024.151598","article-title":"'Different populations of A(H1N1)pdm09 viruses in a patient with hemolytic-uremic syndrome'","volume":"314","author":"Fu","year":"2024","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2026.151745_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015097","article-title":"The population impact of a large school-based influenza vaccination campaign","volume":"5","author":"Grijalva","year":"2010","journal-title":"PLoS. One"},{"key":"10.1016\/j.ijmm.2026.151745_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00003088-199937060-00003","article-title":"Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802","volume":"37","author":"He","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijmm.2026.151745_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8c","author":"Hurt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ijmm.2026.151745_bib19","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3201\/eid2206.151037","article-title":"Debate regarding oseltamivir use for seasonal and pandemic influenza","volume":"22","author":"Hurt","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijmm.2026.151745_bib20","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.23.19884-en","article-title":"Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation","volume":"16","author":"Hurt","year":"2011","journal-title":"' Eur. Surveill."},{"key":"10.1016\/j.ijmm.2026.151745_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106217","article-title":"Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020-2023","volume":"241","author":"Hussain","year":"2025","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijmm.2026.151745_bib22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/QCO.0000000000000498","article-title":"Neuraminidase inhibitor resistance in influenza: a clinical perspective","volume":"31","author":"Lee","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijmm.2026.151745_bib23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2666-5247(24)00037-5","article-title":"Global emergence of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses with I223V and S247N mutations: implications for antiviral resistance monitoring","volume":"5","author":"Leung","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijmm.2026.151745_bib24","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1128\/JVI.77.15.8418-8425.2003","article-title":"Overexpression of the -2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors","volume":"77","author":"Matrosovich","year":"2003","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijmm.2026.151745_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/irv.12047","article-title":"Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance","volume":"7","author":"McKimm-Breschkin","year":"2013","journal-title":"Influenza Other Respir. Virus"},{"key":"10.1016\/j.ijmm.2026.151745_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199182","article-title":"Phylogenetic analysis and docking study of neuraminidase gene of influenza A\/H1N1 viruses circulating in Iran from 2010 to 2019","volume":"334","author":"Moeini","year":"2023","journal-title":"Virus Res."},{"key":"10.1016\/j.ijmm.2026.151745_bib27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1086\/656439","article-title":"Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y\/I223R mutation from a child after prolonged treatment with oseltamivir","volume":"51","author":"Nguyen","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijmm.2026.151745_bib28","article-title":"Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: analysis of national surveillance data","volume":"6","author":"Oh","year":"2021","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.ijmm.2026.151745_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2147\/IDR.S389263","article-title":"'Preparing for the next influenza season: monitoring the emergence and spread of antiviral resistance'","volume":"16","author":"Oh","year":"2023","journal-title":"Infect. Drug. Resist."},{"key":"10.1016\/j.ijmm.2026.151745_bib30","first-page":"1410","article-title":"Multicountry spread of influenza A(H1N1)pdm09 viruses with reduced oseltamivir inhibition","volume":"30","author":"Patel","year":"2024","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijmm.2026.151745_bib31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3851\/IMP3141","article-title":"Prospective surveillance of antiviral resistance in hospitalized infants less than 12 months of age with A(H3N2) influenza infection and treated with oseltamivir","volume":"22","author":"Rath","year":"2017","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ijmm.2026.151745_bib32","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2025.30.48.2500873","article-title":"Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025","volume":"30","author":"Saubi","year":"2025","journal-title":"' Eur. Surveill."},{"key":"10.1016\/j.ijmm.2026.151745_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-087397","article-title":"Summary of WHO clinical practice guidelines for influenza","volume":"392","author":"Vandvik","year":"2026","journal-title":"BMJ"},{"key":"10.1016\/j.ijmm.2026.151745_bib34","unstructured":"WHO. 2012. 'Meetings of the WHO working group on surveillance of influenza antiviral susceptibility- Geneva, November 2011 and June 2012', Accessed 2025, November 25. https:\/\/iris.who.int\/handle\/10665\/241968."},{"key":"10.1016\/j.ijmm.2026.151745_bib35","unstructured":"WHO. 2018. 'Practical guidance for national influenza centres establishing or implementing neuraminidase inhibitor susceptibility surveillance', Accessed 2026, May 04. https:\/\/www.who.int\/publications\/i\/item\/practical-guidance-for-national-influenza-centres-establishing-or-implementing-neuraminidase-inhibitor-susceptibility-surveillance."},{"key":"10.1016\/j.ijmm.2026.151745_bib36","unstructured":"WHO. 2023. 'Summary of neuraminidase (NA) amino acid substitutions assessed for their effects on inhibition by neuraminidase inhibitors (NAIs).', WHO, Accessed 2026, June, 15. https:\/\/www.who.int\/publications\/m\/item\/summary-of-neuraminidase-(na)-amino-acid-substitutions-associated-with-reduced-inhibition-by-neuraminidase-inhibitors-(nais)."},{"key":"10.1016\/j.ijmm.2026.151745_bib37","unstructured":"WHO. 2025. 'Influenza (Seasonal) Fact sheet February 2025', Accessed 2026, May 26. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"10.1016\/j.ijmm.2026.151745_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1021\/acs.jcim.5b00331","article-title":"H274Y's effect on oseltamivir resistance: what happens before the drug enters the binding site","volume":"56","author":"Yusuf","year":"2016","journal-title":"J. Chem. Inf. Model."}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422126000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422126000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:07:52Z","timestamp":1793938072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422126000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":38,"alternative-id":["S1438422126000482"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2026.151745","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased circulation of influenza A(H1N1)pdm09 viruses with reduced susceptibility to oseltamivir, Germany 2024\u20132026","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2026.151745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151745"}}